First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach is a research paper published in Journal for ImmunoTherapy of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P50-CA190991-05
National Cancer Institute
Grant: R01-CA177476-05
National Institute of Neurological Disorders and Stroke
Grant: R01-NS085412-05
National Institute of Neurological Disorders and Stroke
Grant: R01-NS099463-04
National Institute of Neurological Disorders and Stroke
Grant: U01-NS090284-04
NCI NIH HHS
Grant: R01 CA177476
NINDS NIH HHS
Grant: R01 NS085412
NIGMS NIH HHS
Grant: T32 GM145449
NINDS NIH HHS
Grant: U01 NS090284
NCI NIH HHS
Grant: F30 CA196199
NCI NIH HHS
Grant: P30 CA014236
NINDS NIH HHS
Grant: R01 NS099463
NCI NIH HHS
Grant: P50 CA190991
FWCI
2.00
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords